Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Rev Epidemiol Sante Publique ; 51(1 Pt 2): 175-82, 2003 Feb.
Article in French | MEDLINE | ID: mdl-12684576

ABSTRACT

The relationship between Plasmodii transmission, infection, morbidity, genetic susceptibility and acquisition of natural immunity is studied among two cohorts in the Senegalese villages of Dielmo (300 inhabitants) and Ndiop (350 inhabitants) where malaria is holoendemic (about 200 P. falciparum infective bites/person/year) and mesoendemic (about 20 P. falciparum infective bites/person/year), respectively. The populations are under a daily active clinical survey. Blood samples are collected at least once per month. Plasma and red blood cells are stored in bio-libraries that allow longitudinal studies of the immune responses against plasmodial antigens and the investigation of the natural history of P. falciparum infections by molecular genotyping methods.


Subject(s)
Blood Banks , Malaria, Falciparum/blood , Malaria, Falciparum/epidemiology , Animals , Blood Preservation , Humans , Plasmodium falciparum/isolation & purification , Population Surveillance , Senegal/epidemiology , Seroepidemiologic Studies , Tropical Climate
2.
South Med J ; 88(5): 514-23, 1995 May.
Article in English | MEDLINE | ID: mdl-7732439

ABSTRACT

To determine patterns of medication use based on clinical variables in patients with heart failure, we analyzed data from 5,999 patients participating in the Registry of Studies of Left Ventricular Dysfunction (SOLVD). The Registry comprised a broad spectrum of patients with heart failure, including some with predominantly diastolic dysfunction. Drug use was determined in a population cross-sectional manner at the time of identification (74% hospitalized). The median number of drugs per patient was four, with diuretics taken by 62%, digitalis by 45%, angiotensin-converting enzyme inhibitors (ACE-I) by 32%, calcium channel blockers by 36%, antiarrhythmics by 22%, and beta-blockers by 18%. Only 18% were on the combination of ACE-I, diuretic, and digitalis. Stratification for diagnosis, heart failure symptoms, and ejection fractions demonstrated that triple-drug therapy (digitalis, diuretic, and ACE-I) was common only in those with ejection fractions less than .20 and several signs or symptoms of heart failure. Older patients were taking diuretics frequently (73% of patients older than 70 years of age), and our European center used fewer drugs overall, while prescribing digitalis about half as frequently as North American clinics. These data serve as the baseline for analysis of evolving therapeutic practice in patients with heart failure.


Subject(s)
Drug Utilization Review , Heart Failure/drug therapy , Practice Patterns, Physicians' , Registries , Ventricular Dysfunction, Left/drug therapy , Aged , Belgium , Calcium Channel Blockers/therapeutic use , Canada , Cross-Sectional Studies , Digitalis , Diuretics/therapeutic use , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Multicenter Studies as Topic , Peptidyl-Dipeptidase A/therapeutic use , Plants, Medicinal , Plants, Toxic , Randomized Controlled Trials as Topic , Stroke Volume , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...